About us Mammalian cell culture Microbial cell culture Downstream processing Assay development FAQS Links Contact us
newslink


Commonly asked questions and Our answers.

Click here to go back to Biosynergy home.

Click on 'Contact Us' above for company location and feedback form or Click below to
Email us now



From Clone to Clinic - Your First Choice Manufacturer

Q How much will it cost to produce 1gm, 10gm, 100gm of purified protein?
A Accuracy of costing is directly proportional to information available on the cell line to be used.
Our short evaluation programme (4-8 weeks) will provide a detailed report on the cell line and its suitability for production. From this information we will provide an accurate costing and timescale for completion of your project.
Downstream processing protocols also affect yield, and for monoclonal antibodies requiring a Protein A purification step, antibody subclass will affect recovery levels.
Talk to us about process development and optimisation before embarking on production campaigns.

Q Is it possible to start production within 4 weeks?
A Yes. Subject to sufficient information being available.
Download, complete and return our customer questionnaire to enable us to give you the answer.

Q Is my cell line suitable for manufacture for clinical trials?
A Refer to our project progression schedule. Is the cell line sufficiently well characterised (stability, sterility, biosafety considerations). Unsure? Talk to us or go to links and talk to BioReliance

Q Being a multi-client, multi-product facility, can you assure confidentiality?
A Yes. Our secure document archiving systems ensure that no breach of confidence occurs. Client and project confidentiality is a core business ethic.

Q How do I know if my cell line is stable?
A Cell lines often contain low or non secreting variants.
High level expression of such variants during long term culture is undesirable.
We will assess your line and generate a cell bank suitable for long term production. Where possible we will select high secreting clones as part of this process, thereby reducing production time.